Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL02
- Pharmacological subgroupL02A
- Chemical subgroupL02AB
- Chemical substanceL02AB01Megestrol
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 17 registrations
- Megestrol160 MG · Tablet · Aa Pharma INC
- Megestrol40 MG · Tablet · Aa Pharma INC
- Apo-Megestrol40 MG · Tablet · Apotex INC
- Apo-Megestrol160 MG · Tablet · Apotex INC
Brazil
Anvisa · 9 registrations
At a glance
- ATC code
- L02AB01
- Registers
- 9
- Historical lists
- 2
- Registrations
- 53
- With their own page
- 27
- Companies
- 29
All medicines with Megestrol
Human medicines from every register that match Megestrol by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
53 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Megestrol | Canada | 160 MG | Tablet | Marketed | Aa Pharma INC |
| Megestrol | Canada | 40 MG | Tablet | Marketed | Aa Pharma INC |
| Megestrol | Canada | 160 MG | Tablet | Authorised | Apotex INC |
| Megestrol | Canada | 40 MG | Tablet | Authorised | Apotex INC |
| Megestrol Acetate | United States | 125MG/ML, 40MG/ML | suspension | Marketed | Teva Pharms |
| Megestrol Acetate | United States | 20MG, 40MG | tablet | Marketed | Barr |
| Megestrolacetaat 160 mg Focus, tabletten | Netherlands | Tablet | Authorised | Focus Care Pharmaceuticals B.V. | |
| Apo-Megestrol | Canada | 40 MG | Tablet | Authorised | Apotex INC |
| Apo-Megestrol | Canada | 160 MG | Tablet | Authorised | Apotex INC |
| APO-MEGESTROL TABLET 40 mg | Singapore | 40 mg | tablet | Authorised | Pharmaforte Singapore Pte LTD |
| APO-MEGESTROL TABLET 160 mg | Singapore | 160 mg | tablet | Authorised | Pharmaforte Singapore Pte LTD |
| Megace | United States | 20MG, 40MG | tablet | Not marketed | Bristol Myers Squibb |
| Megace | United States | 40MG/ML | suspension | Not marketed | Bristol Myers Squibb |
| Megace Es | United States | 125MG/ML | suspension | Not marketed | Endo Operations |
| Femigestrol | Brazil | Authorised | Laboratorio Quimico Farmaceutico Bergamo Ltda | ||
| Megace® | Serbia | 40mg/mL | oralna suspenzija | Authorised | Pharmaswiss D.O.O., Beograd |
| Megace® | Serbia | 40mg/mL | oralna suspenzija | Authorised | Pharmaswiss D.O.O., Beograd |
| Megace® | Serbia | 160mg | tableta | Authorised | Pharmaswiss D.O.O., Beograd |
| BOREA 160 mg COMPRIMIDOS | Spain | 160 mg | comprimido | Marketed | Viatris Healthcare Limited |
| MAYGACE ALTAS DOSIS 40 mg/ml SUSPENSION ORAL | Spain | 40 mg | suspensión oral | Marketed | Bausch Health Ireland Limited |
| BOREA 160 mg GRANULADO PARA SUSPENSION ORAL EN SOBRES | Spain | 160 mg | granulado | Marketed | Viatris Healthcare Limited |
| Megex-I suspension | Taiwan | 懸液劑 | Authorised | 韋淳貿易股份有限公司 | |
| Megace 160 mg tablete | Croatia | tableta | Marketed | Bausch Health Ireland Limited | |
| Megostat 40 mg/ml oralna suspenzija | Croatia | oralna suspenzija | Marketed | Bausch Health Ireland Limited | |
| Megatus Oral Suspension 40mg/ml | Taiwan | 懸液劑 | Authorised | 美時化學製藥股份有限公司 |